163 related articles for article (PubMed ID: 32587638)
1. Pentraxin 3 (PTX-3) Levels in Bronchoalveolar Lavage Fluid as a Lung Cancer Biomarker.
Hu T; Qiao L; Li H; Ren H; Ning Q; Zhou H; Chen X; Sun Z; Shen L
Dis Markers; 2020; 2020():4652483. PubMed ID: 32587638
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and prognostic value of pentraxin-3 as serologic biomarker for lung cancer.
Zhang D; Ren WH; Gao Y; Wang NY; Wu WJ
Asian Pac J Cancer Prev; 2013; 14(7):4215-21. PubMed ID: 23991979
[TBL] [Abstract][Full Text] [Related]
3. Pentraxin-3 as a prognostic marker in patients with small-cell lung cancer.
Liu C; Yao Y; Wang W
Med Oncol; 2014 Oct; 31(10):207. PubMed ID: 25178940
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].
Huang F; Wang XL; Geng Y; Li MX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):507-9. PubMed ID: 15989803
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
[TBL] [Abstract][Full Text] [Related]
7. Analyzing the percentage of different PD-1
Hu X; Gu Y; Li D; Zhao S; Hua S; Jiang Y
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1074-1083. PubMed ID: 31381177
[TBL] [Abstract][Full Text] [Related]
8. IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).
Pastor MD; Nogal A; Molina-Pinelo S; Quintanal-Villalonga Á; Meléndez R; Ferrer I; Romero-Romero B; De Miguel MJ; López-Campos JL; Corral J; García-Carboner R; Carnero A; Paz-Ares L
J Thorac Oncol; 2016 Dec; 11(12):2183-2192. PubMed ID: 27524264
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis of bronchoalveolar lavage fluids from patients with small cell lung cancers.
Vu HM; Mohammad HB; Nguyen TNC; Lee JH; Do Y; Sung JY; Lee SH; Kim MS
Proteomics Clin Appl; 2023 Sep; 17(5):e2300011. PubMed ID: 36807835
[TBL] [Abstract][Full Text] [Related]
10. Vascular Endothelial Growth Factor-D (VEGF-D) is Elevated in Bronchoalveolar Lavage Fluid of Patients with Lung Squamous Carcinoma.
Lv D; Tan L; Zhang Q; Ma H; Zhang Y; Zhang Q; Yu Y; Chen Z; Ding Q; Deng Z
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775896
[TBL] [Abstract][Full Text] [Related]
11. Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.
Ozsu S; Abul Y; Mentese A; Bektas H; Uzun A; Ozlu T; Porcel JM
Respirology; 2013 May; 18(4):657-62. PubMed ID: 23286371
[TBL] [Abstract][Full Text] [Related]
12. The predictive and diagnostic accuracy of long pentraxin-3 in COVID-19 pneumonia.
Genç AB; Yaylacı S; Dheir H; Genç AC; İşsever K; Çekiç D; Kocayiğit H; Çokluk E; Karacan A; Şekeroğlu MR; Toptan Çakar H; Güçlü E
Turk J Med Sci; 2021 Apr; 51(2):448-453. PubMed ID: 33315349
[TBL] [Abstract][Full Text] [Related]
13. B Cell-Attracting Chemokine-1 and Progranulin in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer: New Prognostic Factors.
Naumnik W; Panek B; Ossolińska M; Naumnik B
Adv Exp Med Biol; 2019; 1150():11-16. PubMed ID: 30357709
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of HMGB-1 and TGF-β Level in Serum and BALF of Advanced Non-Small Cell Lung Cancer.
Jakubowska K; Naumnik W; Niklińska W; Chyczewska E
Adv Exp Med Biol; 2015; 852():49-58. PubMed ID: 25753556
[TBL] [Abstract][Full Text] [Related]
15. Eicosanoids in exhaled breath condensate and bronchoalveolar lavage fluid of patients with primary lung cancer.
Ciebiada M; Górski P; Antczak A
Dis Markers; 2012; 32(5):329-35. PubMed ID: 22674413
[TBL] [Abstract][Full Text] [Related]
16. Pentraxin 3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with pulmonary aspergillosis.
Li H; Liu L; Zhou W; Rui Y; He B; Shi Y; Su X
Clin Microbiol Infect; 2019 Apr; 25(4):504-510. PubMed ID: 29964232
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.
Infante M; Allavena P; Garlanda C; Nebuloni M; Morenghi E; Rahal D; Roncalli M; Cavuto S; Pesce S; Monari M; Valaperta S; Montanelli A; Solomon D; Bottoni E; Errico V; Voulaz E; Bossi M; Chiesa G; Passera E; Mantovani A; Alloisio M
Int J Cancer; 2016 Feb; 138(4):983-91. PubMed ID: 26348770
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer].
Dabrowska M; Grubek-Jaworska H; Domagała-Kulawik J; Bartoszewicz Z; Kondracka A; Krenke R; Nejman P; Chazan R
Pol Arch Med Wewn; 2004 Jun; 111(6):659-65. PubMed ID: 15508787
[TBL] [Abstract][Full Text] [Related]
19. Utility of VEGF and sVEGFR-1 in bronchoalveolar lavage fluid for differential diagnosis of primary lung cancer.
Cao C; Sun SF; Lv D; Chen ZB; Ding QL; Deng ZC
Asian Pac J Cancer Prev; 2013; 14(4):2443-6. PubMed ID: 23725155
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study.
Naumnik W; Naumnik B; Niewiarowska K; Ossolinska M; Chyczewska E
Adv Exp Med Biol; 2013; 788():341-8. PubMed ID: 23835996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]